Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Maryland, Baltimore
Age
18–54
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
DSM-IV diagnosis of schizophrenia or schizoaffective disorder
Male or Female
Age: 18 to 54 years
Caucasian or Non-Caucasian
Body Mass Index of ≥ 27 kg/m2
One month of stable antipsychotic treatment (same medication regimen and same dose)
You may not be if
History of organic brain disease
DSM-IV diagnosis of Mental Retardation
DSM-IV diagnosis of Alcohol or Substance Dependence within the last six months (except nicotine)
DSM-IV diagnosis of Alcohol or Substance Abuse within the last one month (except nicotine)
Are pregnant or lactating
Meet DSM-IV criteria for a past and/or current eating disorder via the SCID, or if they have a past medical history of an eating disorder, received treatment/counseling for an eating disorder and/or required hospitalization for an eating disorder. (If an otherwise undiagnosed eating disorder is detected during screening, referral to treatment will be provided.)
Are taking weight-loss medications, whether over-the-counter (i.e. Hydroxycut, Stacker products, Metabo-Plus, CortiSlim), or prescribed, including appetite suppressants (Didrex, Tenuate, Sanorex, Mazanor, Adipex-P, Meridia, and Phentermine) and fat-absorption inhibitors (Xenical).
Have cognitive impairment severe enough to preclude informed consent or valid responses on questionnaires. This is defined an as a score of less than 10 on the Evaluation to Sign Consent (ESC).
Have a medical illness, dietary restrictions, or food allergies that, in the view of the investigators, would compromise participation.
Are taking prostaglandins such as dinoprostone or misoprostol (because they interact with oxytocin).
Clareo Health | Effects of Intranasal Oxytocin on Satiety Signaling in People With Schizophrenia
